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Cancers of the distal rectum pose the double problem of local
tumour control and sphincter preservation. Abdominoperineal
resection (APR), long considered the standard treatment of
tumours with a distal edge located up to 6 cm from the anal verge,
provides local control in a substantial majority of cases, but the
resulting loss of sphincter function represents a psychological
burden for many patients (MacDonald and Anderson, 1985;
Billingham, 1992). Consequently there has been a resurgence of
interest in sphincter-conserving surgical approaches, under the
suppostition that the quality of life (QOL) of such patients should
thereby be improved. A more precise understanding of failure
patterns, leading to the acceptance of distal margins of less than 
2 cm, and the recent progress in bowel stapling techniques have
made coloanal anastomoses feasible after low rectal excision. This
latter approach is often associated with preoperative radiotherapy
(RT), which may be considered to compensate for the limitations
of the surgical technique resulting from narrow radial and distal
surgical margins (Papillon and Gerard, 1990; Marks et al, 1993;
Rouanet et al, 1995).
Most reports on the feasibility and results of sphincter-
conserving approaches in low rectal cancers originate from centres
with long-standing research interest in this area. However, there
are few data concerning the applicability of these techniques in a
routine general hospital surgical practice. The aims of the present
study were, first, to assess retrospectively the choice of surgical
procedure and the results obtained in a contemporary series of
patients presenting with low-lying rectal cancers who were treated
with preoperative RT in two Swiss general hospitals. The second
was to formally assess QOL outcomes in patients treated with
restorative procedures, compared with those in patients after APR.
METHODS
Patients
From November 1991 to September 1997, 53 consecutive patients
with primary cancers involving the distal rectum (up to 6 cm or
less from the anal verge) were treated by preoperative RT, with or
without concomitant chemotherapy, at the University Hospital of
Geneva or the Regional Hospital of Bellinzona. The aim of the
preoperative RT was essentially to achieve down-staging in T2
tumours, while for T3–T4 tumours the aim was both improvement
of local control and down-staging. All patients had a pretreatment
biopsy diagnosis of adenocarcinoma (nine well-differentiated, 39
moderately differentiated, three poorly differentiated and unspeci-
fied in two cases). Pretreatment evaluation included physical
examination, proctoscopy and/or colonoscopy, abdominal/pelvic
computerized tomography (CT), chest X-ray and serum carcino-
embryonic antigen (CEA). Transrectal ultrasound was carried out
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caudal edge of the tumour was assessed by proctoscopy and/or
digital examination. All tumours were classified according to the
TNM system of the Union International Contre le Cancer (1992).
The preoperative tumour classification was determined using
information from the digital examination (including assessment of
mobility), CT scan and/or transrectal ultrasound, when available.
Pretreatment patient characteristics are displayed in Table 1.
Preoperative therapy
All patients were treated with external megavoltage (6–18 MV)
photon beams. A 3- or 4-field technique was used in most patients,
except for seven patients treated with opposed antero-posterior
pelvic fields. The median dose to the pelvic volume was 45 Gy in
25 fractions over 5 weeks (range 25.2–50.4 Gy). Ten patients
received a boost of 5.4 Gy in 3 fractions directed to the tumour
with 2–3 cm margin to attain a total tumour dose of 50.4 Gy.
During RT, 30 patients received 5-fluorouracil (5-FU)-based
chemotherapy, either in daily continuous administration (16
patients), or as intravenous (i.v.) bolus for 3–5 days during weeks
1 and 5 (14 patients). After surgery, patients with pathological
nodal involvement or distant metastasis usually received post-
operative 5-FU-based chemotherapy.
Surgery
Surgery was performed at a median interval of 29 days (range
12–96 days) from completion of RT. While surgery was recom-
mended to be carried out 4–6 weeks after RT, some patients were
operated on either earlier or later, mainly due to patient prefer-
ences. APR was carried out in 29 patients, low anterior resection
(LAR) in 23 patients (20 with coloanal and three with colorectal
anastomoses) and transrectal excision in one patient. A temporary
transverse colostomy was performed in 13 patients and a J colonic
pouch in 14 patients. Of three patients found to have hepatic
metastases at surgery, one underwent apparently complete resec-
tion of liver metastases.
In patients undergoing LAR with coloanal anastomosis, the
technique was standardized according to the following steps: the
left colon with the splenic flexure was mobilized after ligature and
section of the inferior mesenteric vein and artery. The mesosig-
moid was then mobilized and the plane of the mesorectum was
entered in continuity as the dissection proceeded distally. This
plane was followed down to the level of the pelvic floor when a
total mesorectal excision (TME) was performed (Heald and Ryall,
1986). The dissection of the rectum and mesorectum was
performed applying slight lateral traction to open the cleavage
plane between the mesorectum and the lateral wall of the pelvis.
This allowed clear visualization and preservation of the pelvic
autonomic nerves. Most patients operated on with TME have had a
defunctioning transverse colostomy.
Anal function assessment
Anal sphincter function was evaluated according to the Memorial
Sloan-Kettering Cancer Center (MSKCC) anal function criteria
(Minsky et al, 1995). The score ‘excellent’ corresponds to 1–2
bowel movements per day and no soilage; ‘good’ corresponds to
3–4 bowel movements per day and/or mild soilage; ‘fair’ corre-
sponds to more than 4 bowel movements per day and/or moderate
soilage, and ‘poor’ corresponds to incontinence. Acute and late
RT-related complications were classified according to the RTOG
grading system (Perez and Brady, 1992).
QOL assessment
Patients were selected for QOL assessment if they had 1-year
minimum follow-up, did not present uncontrolled locoregional
failure, were not under treatment for distant metastases and
accepted participation in the study. QOL was assessed by using
two questionnaires developed by the QOL Study Group of the
European Organization for Research and Treatment of Cancer: a
validated questionnaire assessing cancer-specific QOL (EORTC
QLQ-C30) (Aaronson et al, 1993) and one assessing site-specific
(colorectal) QOL (EORTC QLQ-CR38), which is in the process of
validation.
EORTC QLQ-C30
This is a patient self-rating questionnaire that comprises six func-
tion scales measuring physical, role, social, emotional and cogni-
tive functions, and overall QOL, as well as symptom scales
assessing pain, fatigue, emesis, bowel function, dyspnoea, appetite
loss and sleep disturbances. A final item evaluates the perceived
economic impact of the disease.
EORTC QLQ-CR38
This module is a patient self-rating questionnaire that comprises
38 questions, of which 19 are completed by all patients and the
remaining by subset of patients (males or females; patients with or
without a stoma). The general structure comprises four multi-
item/single-function scales (assessing body image, sexual func-
tioning, sexual enjoyment and future perspective), seven symptom
scales (assessing radiotherapy side-effects on micturition,
chemotherapy side-effects, gastrointestinal general symptoms,
defecation problems, stoma-related problems and sexual dysfunc-
tion in males or females) and one single-symptom item assessing
weight loss. This module has been validated in The Netherlands
and is currently being used in a wide range of cross-cultural
studies (Sprangers et al, 1999).
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Table 1 Pretreatment patient characteristics (53)
Age, mean (s.d.) 64 years (9)
Gender, male/female 37/16
WHO performance status
03 7
1–2 16
Distance from anal verge to the
lower tumour edge (cm)
Mean (s.d.) 3.7 (1.5)
Maximum tumour dimension (cm)
Mean (s.d.) 7 (3)
TNM stage
T2 5
T3 31
T4 17
N0 42
N1 11
M0 51
M1 1
Mx 1Statistical analyses
Actuarial locoregional control, overall and disease-free survival
rates were calculated by the product-limit method (Kaplan and
Meier, 1958). The log-rank test was used to compare survival
curves, the Mann–Whitney U-test to compare median scores of
QOL scales (considering the non-Gaussian distribution of these
scores), and the Student’s t-test to compare the means of the
remaining outcome variables. A difference with a P-value < 0.05
was considered as significant.
All scores of the QLQ-C30 and QLQ-CR38 were linearly
transformed such that all scales range from 0 to 100. The higher
scale score represents a higher level of functioning for the six
(QLQ-C30) and four (QLQ-CR38) multi-item/single-function
scales and a higher level of symptomatology/problems for the
symptom/single-item scales. We hypothesized that at least some
scores of the various scales would vary between subgroups of
patients according to the type of surgery, particularly levels of
physical and social functions, overall quality of life, body image
and sexual functioning that were expected to be higher in patients
with a conserved anal sphincter.
RESULTS
Pathologic findings
At pathological evaluation of the resection specimen, 12 patients
(22.5%) had a marked response to preoperative therapy, including
four patients (7.5%) with a microscopically complete response,
and eight (15%) with only microscopically residual carcinoma.
The remaining 41 patients had a partial response or no change.
Post-RT pathological tumour stages were four pT0, four pT1, 16
pT2, 24 pT3 and five pT4. Sixteen patients had positive lymph
nodes (13 pN1 and three pN2), and three patients had hepatic
metastases. All patients with positive nodes or distant metastases
had partial response or no change of their primary tumour after RT.
The mean interval between RT and surgery was 42 days for
patients having complete pathological response or microscopic
residual disease, compared with 33.5 days for patients with partial
response or no change (P = 0.15). For patients undergoing LAR,
the mean pathologic distal free margin was 2.2 cm (standard devi-
ation (s.d.) 1.24, range 0.3–4 cm). Surgical margins were negative
in 49 patients, positive in one and uncertain in three.
Choice of surgical procedure
Indications regarding the type of surgical procedure foreseen was
available in the clinical records of all patients prior to RT. APR
was planned in 21 patients, a restorative procedure in seven
patients, and in 25 patients the decision was intended to be made as
a function of the tumour response to preoperative treatment. The
final decision was taken by the surgeon in the immediate preoper-
ative period according essentially to the tumour response. Table 2
displays the comparison of the planned type of surgery to the
procedure actually performed. The mean distance from the anal
verge to the tumour was 3 cm (s.d. 1.45, range 0.5–6 cm) and 
4.5 cm (s.d. 1.25, range 1.5–6 cm) in patients operated by APR
and LAR respectively (P = 0.0007).
Toxicity
During preoperative therapy, 63% of patients presented with grade
1–2, 33% with grade 3 and one patient with a grade 4 acute toxi-
city. Acute complications involved the perineal skin in most cases,
while diarrhoea, proctitis and urinary tract symptoms (dysuria,
urgency, frequency) were commonly observed reactions. The
grade 4 toxicity consisted of an acute small bowel obstruction
managed conservatively, occurring at a dose of 25.2 Gy delivered
by a 2-field technique in a patient receiving a continuous 5-FU
infusion (treatment stopped definitively). One grade 3 leukopenia
and one case of venous thrombosis were also documented.
Thirteen patients presented with post-operative complications:
six in the APR group and seven in the conservation surgery group.
There were two abdominal wound dehiscences (one treated surgi-
cally), three perineal and three abdominal wound abscesses, one
colic ischaemia (treated surgically), one fistula after colostomy
closing and three partial anastomotic disruptions (one managed
surgically).
During follow-up, two patients from the restorative surgery
group required surgical treatment for a late complication. One
presented with small bowel obstruction managed surgically, and
one presented with a presacral abscess requiring a definitive
sigmoidostomy. Among 11 patients having had sphincter-saving
surgery with a minimum of 1-year follow-up, the MSKCC anal
function score was excellent in seven cases, good in two and fair in
two.
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Table 2 Type of resection performed in relation to the procedure originally
planned
Planned surgery No. of  Performed surgery No. of
patients patients (%)
APR 21 APR 19 (90.5)
Restorative surgery 2 (9.5)
Restorative surgery 7 APR 3 (43)
Restorative surgery 4 (57)
According to
tumour response 25 APR 7 (28)
Restorative surgery 18 (72)
APR, abdomino-perineal resection.
P = 0.26
RS group (24 patients)
APR group (29 patients)
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Figure 1 Actuarial disease-free survival in the two surgical groups. APR,
abdomino-perineal resection; RS: restorative surgeryOncologic results
With a median follow-up of 23 months (range 4–74 months) from
the start of RT, nine patients have died: five of rectal cancer, two of
a second malignancy, one from intercurrent disease and one from
unknown cause. The 3-year actuarial survival for all patients was
71.4% (95% confidence interval (CI) 53–89%).
During follow-up, 15 patients presented with disease progres-
sion. Locoregional failures were observed in seven patients, either
alone (four) or with distant metastasis (three). Distant metastasis
alone occurred in nine patients, involving either the lung (seven)
or the liver (five). The 3-year actuarial locoregional control rates
were 77.5% (95% CI 61–93) for all patients, 100% for the 12
patients with marked pathological tumour response to RT, and
73% for the remaining patients. The 3-year disease-free survival
rates were 58% (95% CI 40–75) for all patients, 89% for patients
with pathological marked response and 52% for the remaining
patients (P = 0.16). According to pathological classification, 3-
year disease-free survival rates were 76% and 47% for patients
with pT0–2 and pT3–4 tumours respectively (P = 0.057). No
significant difference in disease-free survival was observed
between patients operated by APR or by restorative surgery
(Figure 1), or between patients receiving preoperative radio-
therapy alone and those treated with radiochemotherapy.
QOL outcomes
Twenty-six patients satisfied the inclusion criteria. All patients
were contacted by telephone to solicit their participation. Twenty-
three patients (88%) gave their approval to participate in the study,
two refused and one was judged ineligible because of serious co-
morbidities. Among the 23 participating patients, 11 were treated
with APR and 12 with sphincter-sparing surgery. There were 17
males and six females. Age at the time of analysis, the median
follow-up time, gender and performance status were similar in the
two surgical groups.
EORTC QLQ-C30 scores
The median and mean scale scores according to the type of surgery
are given in Table 3. For all scale scores, no significant differences
in medians were observed between the two surgical groups.
Patients having undergone restorative surgery tended to report
higher levels of constipation (P = 0.09). Although patients having
had APR seem to have more sleep disturbances, they tended to
report higher levels of physical functioning and global QOL than
did patients having had restorative resections.
EORTC QLQ-CR38 scores
The general results for the two surgical groups are given in Table
4. No significant differences in median scores were observed
between the two surgical groups for any of the scales. However,
APR group patients tended to report a lower body image score 
(P = 0.12) but a higher future perspective score. The sexual func-
tioning score was very low in both groups. In males, sexual
dysfunction symptom score was higher in the APR group. None of
females responded to questions concerning the sexual dysfunction
scale. The symptom score related to anorectal function in patients
having had restorative surgery was comparable to the symptom
score related to the stoma in the subgroup having had APR.
DISCUSSION
In solid tumour oncology the past two decades have been marked by
the success of multimodality treatment programmes aiming at
respecting body integrity and attempting to preserve organ function.
For cancers of the distal rectum the development of such therapeutic
approaches in many centres has already resulted in a restriction in
the indications for APR. While restorative surgical procedures have
long been proposed for highly selected superficial lesions, the avail-
ability of sophisticated bowel stapling techniques has allowed
restorative procedures to be applied to a much wider spectrum of
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Table 3 EORTC QLQ-C30 mean and median scale and single-item scores according to the type of surgery
APR group Restorative surgery group Pa
(11 patients) (12 patients)
Means (s.d.) Medians (range) Means (s.d.) Medians (range)
Functional scales
Physical function 87 (22) 100 (40–100) 70 (34) 80 (0–100) 0.2
Role function 86 (19) 83 (33–100) 77 (32) 100 (16–100) 0.97
Emotional function 84 (24) 91 (33–100) 82 (21) 91 (41–100) 0.8
Cognitive function 88 (17) 100 (50–100) 85 (23) 100 (33–100) 0.95
Social function 85 (16) 83 (66–100) 78 (35) 100 (0–100) 0.87
Global quality of life 78 (14) 83 (58–100) 67 (25) 66 (33–100) 0.38
Symptom scales
Fatigue 24 (33) 11 (0–100) 25 (25) 16 (0–66) 0.68
Pain 10 (13) 0 (0–33) 18 (22) 16 (0–66) 0.49
Nausea and vomiting 1.5 (5) 0 (0–16) 3 (9) 0 (0–33) 0.99
Single items
Dyspnoea 6 (13) 0 (0–33) 14 (22) 0 (0–66) 0.49
Sleep disturbance 18 (17) 33 (0–33) 14 (33) 0 (0–100) 0.24
Appetite loss 6 (13) 0 (0–33) 3 (9) 0 (0–33) 0.68
Diarrhoea 9 (15) 0 (0–33) 16 (26) 0 (0–66) 0.66
Constipation 0 (0) 0 (0–0) 22 (29) 0 (0–66) 0.09
Financial impact 18 (34) 0 (0–100) 19 (36) 0 (0–100) 0.97
APR, abdomino-perineal resection; s.d., standard deviations; aP-value refers to the Mann–Whitney U-tests testing for
differences in medians (the means are given for informative purposes).patients with rectal cancers (Papillon and Gerard, 1990; Marks et al,
1993). Preoperative RT can potentially increase the feasibility of
sphincter-saving resections by reducing the tumour volume and by
sterilizing local tumour extensions, compensating thereby for the
very narrow lateral and caudal resection margins (Papillon and
Gerard, 1990; Marks et al, 1993; Rouanet, 1995; Allal, 1996). The
apparently satisfactory oncological results thus obtained, especially
when viewed in the light of QOL end points, has led to the
increasing use of multimodal restorative approaches.
To assess the incorporation of these therapeutic strategies into
our routine practice, we analysed the choice of surgical proce-
dures, oncological results and QOL outcomes in a recent series of
53 patients with cancers involving the distal rectum, the large
majority of whom would have been submitted to APR little more
than a decade ago (Williams et al, 1983a; Billingham, 1992). We
found that 24 patients (45%) were able to undergo restorative
surgical procedures, in 20 cases using LAR with coloanal anasto-
mosis. Moreover, in 25 patients (47%) the decision regarding the
type of surgery was not taken at initial surgical consultation, but
rather was explicitly based upon the quality of tumour response to
preoperative therapy. The proportion of sphincter-saving proce-
dures appears low compared with the 76–83% rates reported in
prospective studies of this approach (Minsky et al, 1995; Rouanet
et al, 1995; Maghfoor et al, 1997). However, this apparent discrep-
ancy may be explained by differences in patient selection, particu-
larly regarding tumour stage and distance from the anal verge.
Indeed, in the series of Minsky et al (1995) and Rouanet et al
(1995), no patients had T4 tumours or lesions extending below 
2.7 cm, whereas in the present series 32% of patients presented
clinically with T4 tumours and 28% of patients had tumours
extending within 2.7 cm from the anal verge. Our findings are
consistent with the 50% rate of restorative resections reported in a
large prospective trial studying the value of preoperative therapy
in unselected patients with rectal carcinomas (Hyams et al, 1997).
It is likely in most cases that the distance between the anal verge
and the lower edge of the tumour continues to dictate the choice of
surgical technique. In the APR group the mean distance between
tumour and anal verge was significantly smaller than that of the
restorative surgery group (3 cm vs 4.5 cm). Based on operative
series, 2 cm is widely considered the minimum distal safety
margin (Polett and Nicholls, 1983; Williams et al, 1983a). In our
patients operated by LAR, the mean distal surgical margin was 
2.2 cm, with 11 (48%) patients having had a safety margin of less
than 2 cm (min 0.3 cm). It is apparent that any increase in the
proportion of restorative procedures could only occur at the
expense of diminishing distal surgical margins. It is noteworthy
that similar outcomes have been reported for patients with < 2 cm
and those with >2 cm safety margins (Polett and Nicholls, 1983),
and it is not excluded that a narrower surgical margin will come to
be considered oncologically acceptable following preoperative RT.
The validity of this notion is already suggested by some series
reporting good locoregional control with mean margins of 1.5 cm
(Rouanet et al, 1995), or for tumours located in the distal 2 cm of
the rectum (Mohiuddin et al, 1998). In the other hand, the quality
of the circumferential surgical margin is known to be crucial for
the oncological outcome (Quirke et al, 1986). However, the
minimum safe free lateral margin remains unknown (Heald and
Karanjia, 1992), particularly in conjunction with preoperative RT.
Considering the relatively advanced stage of patients in the
present series, the 3-year locoregional control rate of 77.5% can be
considered as satisfactory. Only two of 24 patients (8%) failed
locally after restorative resections, consistent with the results of
reported series using preoperative RT (Marks et al, 1993; Minsky
et al, 1995; Rouanet et al, 1995). The relatively low disease-free
survival rate (58%) reflects the rather unfavourable initial disease
presentation, with three patients already having distant metastases
at time of surgery. No significant differences in outcomes were
observed between the two surgical groups. However, it is note-
worthy that patients presenting with marked pathological tumour
response, with absent or only microscopic residual cancer after
preoperative therapy, had a more favourable outcome. No loco-
regional recurrence and only one distant metastasis (8%) was
observed in these 12 patients, compared with seven locoregional
failures (17%) and 14 metastases (34%) in tumours showing no
change or only partial response. Thus, as suggested by others
(Berger et al, 1997), post-RT down-staging may have a certain
prognostic value. Whether the improved outcome can be attributed
to the effect of preoperative therapy or to particular clinical or
biological characteristics of the responding tumours remains
speculative.
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Table 4 EORTC QLQ-CR38 mean and median functional scale and symptom scores according to the type of surgery
Scales No. patients APR group Restorative surgery group Pa
APR/Restorative
Functional scales Means (s.d.) Medians (range) Means (s.d.) Medians (range)
Body image 11/12 72 (25) 77 (33–100) 87 (25) 100 (33–100) 0.12
Future perspective 10/12 80 (23) 83 (33–100) 66 (31) 66 (0–100) 0.35
Sexual functioning 11/11 27 (32) 16 (0–100) 18 (20) 16 (0–66) 0.71
Sexual enjoyment 5/7 60 (28) 66 (33–100) 47 (32) 33 (0–100) 0.51
Symptom scales
RT side-effects on micturition 11/12 20 (25) 11 (0–66) 23 (22) 22 (0–66) 0.68
General gastro-intestinal 11/12 12 (10) 13 (0–33) 15 (13) 13 (0–46) 0.53
Defecation problems –/12 – – 17 (15) 14 (0–52) –
Stoma-related problems 11/– 20 (22) 14 (0–76) – – –
Sexual dysfuntion of males 8/6 50 (30) 50 (0–100) 33 (27) 25 (0–66) 0.33
Sexual dysfuntion of females 0/0 – – – – –
Weight loss 11/12 0 (0) 0 (0–0) 8 (20) 0 (0–66) 0.49
APR, abdomino-perineal resection; s.d., standard deviations; aP-value refers to the Mann–Whitney U-tests testing for differences in
medians (the means are given for informative purposes).Despite certain weaknesses that are inherent to the retrospective
design of the present study (different RT techniques, different
chemotherapy regimens) acute tolerance of preoperative treatment
appeared acceptable in our hands, with all patients but one
completing the planned programme. The single patient developing
partial small bowel obstruction during preoperative therapy was
receiving continuous 5-FU chemotherapy and was treated with
opposed pelvic fields, a technique that is known to irradiate unac-
ceptably large normal tissue volumes. This latter technique was used
in the initial period of the study in one institution and was changed
definitively after. Otherwise the 33% rate of grade 3 acute reactions
is similar to those reported in the literature (Grann et al, 1997). In the
perioperative period no fatal complication was observed, whilst
partial anastomotic disruption was observed in three patients.
Whether these latter complications were related to the preoperative
RT remains speculative (Friedmann et al, 1987). Only one patient
needed a permanent stoma for a late complication after restorative
surgery. Similar rates of post-operative complications were reported
in other series (Minsky et al, 1995; Rouanet et al, 1995).
We were able to assess anal sphincter function in 11 patients
having undergone restorative resections and alive without recur-
rence at a minimum follow-up of 1 year. According to the MSKCC
score, function was good to excellent in 9/11 patients (82%),
whilst two patients had fair function. These results are similar to
those of Minsky et al (1995) and Rouanet et al (1995), who
reported 77% good to excellent and 71% perfect anal function
respectively. However, a large number of evaluable patients and
longer follow-up are needed to obtain a more precise notion of
anal function in this subset of patients. It is noteworthy that
prospective trials have shown a higher rate of long-term anorectal
dysfunction in patients treated with either preoperative (Dahlberg
et al, 1998) or post-operative RT (Lundby et al, 1997) compared
with patients treated with surgery alone. Moreover, results can
vary widely according to the scoring system and the use of subjec-
tive or objective tools (Lewis et al, 1995).
It is generally believed that patients having had sphincter-
conserving procedures enjoy better QOL outcomes than patients
with APR (Williams and Johnston, 1983; Marquis et al, 1992). In a
review of 17 studies assessing QOL in colorectal cancer patients,
both those with and those without stomas reported impairment in
the four QOL domains studied (physical, psychological, social and
sexual), whilst the latter domain was more affected in stoma
patients (Sprangers et al, 1995). However, the magnitude of the
differences in the scores, particularly in the sexual domain, varied
widely, and the results were sometimes inconsistent. Moreover,
the lack of a prospective study design, the clear difference in
patient characteristics, particularly regarding age and the
sphincter-conserving procedures used, may prevent a direct
extrapolation of these findings to patients with coloanal anasto-
moses after preoperative RT.
Aware of the modest size of our study, we tried to assess QOL
outcomes in the two surgical groups of patients. By using the
cancer-specific EORTC-QLQ-C30 questionnaire, no significant
differences in median scores were observed in any of the function
scales studied (physical, role, social, emotional and cognitive
functions, as well as overall QOL). Interestingly some scores, such
as physical and overall QOL scores, were even higher in the APR
group. This finding seems to be in contradiction with the results of
some authors (Frigell et al, 1990; Williams and Johnston, 1983;
MacDonald and Anderson, 1985), who reported better general
QOL and physical activity in non-stoma patients, while general
state of health was reported to be similar in another large series
(Wirsching et al, 1975). This finding can be explained partially by
the fact that, unlike many other series, the two groups of patients
were equally distributed according to age, WHO performance
status, gender, and median follow-up, all of which are important
parameters when assessing QOL outcomes. However, one should
note that only five of 12 patients in the restorative surgery group
had a J pouch, a technical aspect that is known to increase the
functional outcome in this subset of patients. For the symptom
scales, whilst non-significant, the restorative group tended to
report higher levels of constipation and pain symptoms, whereas
the APR group tended to report more sleeping disturbance. Others
authors also find more frequent complaints of constipation in non-
stoma patients (Williams and Johnston, 1983; MacDonald and
Anderson, 1985), and more sleeping disturbances in stoma
patients were noted in another series (Frigell et al, 1990).
The site-specific EORTC-QLQ-CR38 questionnaire confirmed
the findings of others (Williams and Johnston, 1983; MacDonald
and Anderson, 1985) that APR was associated with a lower body
image score and a higher sexual dysfunction score in males,
although statistical significance could not be demonstrated in this
small study. Moreover, it is noteworthy that the sexual functioning
score was very low for both surgical groups, and that no differences
were apparent in the sexual enjoyment scale. Development of nerve-
sparing surgical procedures may play an important role in
preventing such complications (Maas et al, 1998). No data could be
provided on sexual dysfunction in females, since no women chose
to answer the proposed questions. Problems of compliance have
been reported in previous studies, especially when questions
concerned sexual aspects of QOL (Klee et al, 1997). Finally,
patients in the APR group tended to report a higher score for future
perspective scale; this is thought to reflect a decreased concern
about their future state of health. It is possible that after APR
patients are more likely to believe that all the potential area of recur-
rence have been removed, leading to a greater sense of security.
In conclusion, this study reinforces the notion of the feasibility
in routine practice of sphincter-saving surgery after preoperative
RT with or without chemotherapy for cancers of the distal rectum.
Preoperative therapy was associated with manageable toxicities,
perioperative complications were acceptable, and the oncological
results in patients having restorative resections appear similar to
those obtained with APR. Any further increase in the proportion of
sphincter-saving procedures will require a decrease in the minimal
acceptable distal safety margins. This solution may be feasible
after preoperative RT, particularly for good responders. Except for
body image and sexual aspects in men, the other dimensions of
QOL in our study were not necessarily better in the restorative
surgery group at 1-year post treatment. However, the small
number of patients studied disallows any formal conclusions, but
rather suggests hypotheses to be studied prospectively. Thus, a
well-designed prospective study would be required to firmly
establish the superiority of restorative procedures regarding QOL
aspects in cancers of the distal rectum.
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